中药调控Wnt/β-catenin信号通路干预肝细胞癌的研究综述
肝细胞癌占原发性肝脏恶性肿瘤的80%,Wnt/β-catenin信号通路参与其发病、免疫应答与耐药。本文综述中药及植物活性代谢物、单味药提取物和复方通过调控该通路不同靶点或相关通路影响肝细胞癌进展,作为手术、靶向和介入治疗的辅助手段改善微环境、逆转耐药并减少副作用,同时强调中药不应替代现代医学一线治疗方案。
要点
- Wnt/β-catenin通路通过基因突变、调控树突状细胞、T细胞和肿瘤细胞及影响耐药参与肝细胞癌发病。
- 中药具有多作用、多靶点、副作用少和改善免疫的特点,联合临床常规治疗可延长生存并降低术后复发率。
- 中药核心价值是提高综合疗效与生活质量,不应替代现代医学一线治疗方案。
核心结论
- 中药及植物活性代谢物、单味药粗提物和中药复方可通过调控Wnt/β-catenin信号通路的不同靶点或相关通路影响肝细胞癌进展。
- 中药作为手术、靶向治疗和介入治疗的辅助手段,可改善肝细胞癌微环境、逆转耐药并减少治疗副作用。
- 中药不应替代现代医学一线治疗方案,其核心价值在于提高患者综合疗效和生活质量。
研究设计与样本
- 本文为综述,围绕Wnt/β-catenin信号通路在肝细胞癌发生发展中的作用及中药调控该通路的研究进行汇总分析。
主要发现
- Wnt/β-catenin通路通过影响基因突变、调控树突状细胞、T细胞和肿瘤细胞以及影响耐药等多种方式影响肝细胞癌。
- 传统化疗存在副作用、限制和耐药等缺点,中药具有多作用、多靶点、副作用少和改善免疫的特征。
- 中药与临床常规疗法联合可延长患者生存并降低术后复发率,为肝细胞癌的缓解和改善提供联合治疗新思路。
临床怎么用
- 可将中药作为手术、靶向治疗和介入治疗的辅助手段,通过调控Wnt/β-catenin通路改善微环境、逆转耐药并减少副作用。
- 临床应明确中药不替代现代医学一线治疗方案,以提升综合疗效和生活质量为核心目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is a prevalent malignant neoplasm of the digestive system, including 80% of primary liver malignancies. The Wnt/β-catenin signaling pathway plays a key role in immune response and tumer resistance. A growing number of studies have shown that the Wnt/β-catenin signaling pathway is involved in the pathogenesis of HCC. The Wnt/β-catenin pathway affects HCC in a variety of ways, including by influencing gene mutations, regulating dendritic cells, T-cells, and tumor cells, and influencing tumer resistance. Presently, conventional chemotherapy exhibits several drawbacks, including side effects, restrictions, and the emergence of tumer resistance. Traditional Chinese medicine (TCM) are characterized by multiple actions, multiple targets, few side effects, and improved immunity, and their combination with common clinical therapies can prolong patient survival and reduce postoperative recurrence rates, providing a new idea of combination therapy for the alleviation and improvement of HCC. This review focuses on TCM as an adjunct to surgery, targeted therapy, interventional therapy to improve the HCC microenvironment, reverse tumer resistance, and reduce treatment side effects by modulating the Wnt signaling pathway. It should be clear that TCM should not replace the first-line treatment plan of modern medicine, and its core value is to improve the comprehensive efficacy and quality of life of patients. This research examines the role of the Wnt/β-catenin signalling system in developing HCC and describes how TCM and plant active metabolites, crude extracts of single botanical drugs and Chinese herbal formulations affect the progression of HCC by modulating different targets of the Wnt/β-catenin signalling pathway or by modulating other pathways related to the Wnt/β-catenin signalling pathway. This review is intended to provide new ideas and options for the prevention and treatment of HCC.
引用
- Zhang Y, Li H, Jiang N, et al. Chinese herbal medicines: the modifier of hepatocellular carcinoma targeting Wnt/β-catenin signaling pathway. Front Pharmacol. 2025. PMID: 40926993. doi:10.3389/fphar.2025.1626251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。